Advertisement
New Zealand markets closed
  • NZX 50

    12,845.64
    +91.06 (+0.71%)
     
  • NZD/USD

    0.6087
    -0.0009 (-0.15%)
     
  • NZD/EUR

    0.5569
    +0.0001 (+0.02%)
     
  • ALL ORDS

    8,491.50
    -7.20 (-0.08%)
     
  • ASX 200

    8,214.50
    -8.50 (-0.10%)
     
  • OIL

    75.33
    -0.52 (-0.69%)
     
  • GOLD

    2,659.70
    +20.40 (+0.77%)
     
  • NASDAQ

    20,241.76
    -27.10 (-0.13%)
     
  • FTSE

    8,231.70
    -6.03 (-0.07%)
     
  • Dow Jones

    42,454.12
    -57.88 (-0.14%)
     
  • DAX

    19,241.90
    +31.00 (+0.16%)
     
  • Hang Seng

    21,251.98
    +614.74 (+2.98%)
     
  • NIKKEI 225

    39,605.80
    +224.91 (+0.57%)
     
  • NZD/JPY

    90.7660
    +0.2730 (+0.30%)
     

Independent Director of Aehr Test Systems Howard Slayen Buys 11% More Shares

Investors who take an interest in Aehr Test Systems, Inc. (NASDAQ:AEHR) should definitely note that the Independent Director, Howard Slayen, recently paid US$15.50 per share to buy US$310k worth of the stock. That's a very solid buy in our book, and increased their holding by a noteworthy 11%.

Check out our latest analysis for Aehr Test Systems

Aehr Test Systems Insider Transactions Over The Last Year

Notably, that recent purchase by Howard Slayen is the biggest insider purchase of Aehr Test Systems shares that we've seen in the last year. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$13.29). While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. In our view, the price an insider pays for shares is very important. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.

Happily, we note that in the last year insiders paid US$490k for 28.74k shares. But they sold 21.27k shares for US$405k. Overall, Aehr Test Systems insiders were net buyers during the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

insider-trading-volume
insider-trading-volume

Aehr Test Systems is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.

Insider Ownership Of Aehr Test Systems

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Aehr Test Systems insiders own about US$23m worth of shares. That equates to 5.5% of the company. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

What Might The Insider Transactions At Aehr Test Systems Tell Us?

It's certainly positive to see the recent insider purchases. And an analysis of the transactions over the last year also gives us confidence. Given that insiders also own a fair bit of Aehr Test Systems we think they are probably pretty confident of a bright future. While it's good to be aware of what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. Be aware that Aehr Test Systems is showing 3 warning signs in our investment analysis, and 2 of those are concerning...

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.